R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects - Test2 - elhamkhani - TriplyDB

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

http://www.wikidata.org/entity/Q28266846

about

Ketamine enantiomers in the rapid and sustained antidepressant effects Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression Ketamine's antidepressant action: beyond NMDA receptor inhibition Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation NMDAR inhibition-independent antidepressant actions of ketamine metabolites.Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine.Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine NMDA Receptors Regulate the Structural Plasticity of Spines and Axonal Boutons in Hippocampal Interneurons.Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism Investigational drugs for treating major depressive disorder.Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis Beyond serotonin: newer antidepressants in the future.Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens.Ketamine: NMDA Receptors and Beyond.Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.Treating to target in major depressive disorder: response to remission to functional recovery.New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Targeting glutamate signalling in depression: progress and prospects.Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.Glutamate-Based Drug Discovery for Novel Antidepressants.On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites.Administration of ketamine for unipolar and bipolar depression.Regional differences in the expression of brain-derived neurotrophic factor (BDNF) pro-peptide, proBDNF and preproBDNF in the brain confer stress resilience.Regional differences in dendritic spine density confer resilience to chronic social defeat stress.Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling.Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype.Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation.Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine.Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects.Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior.Special Topic on Mental Health and Addiction.Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions.Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.

P2860

Q26746141-0B682442-AA8C-4AE8-90C2-B5125AB528BD Q28277636-51306D9A-9DB6-4BBA-A74B-822ABCAEA3EF Q28278684-15E90FBF-E669-4947-A4D6-7A9A222A1295 Q28385414-0EAC2740-38FE-4595-A19D-7D5BB1C4E108 Q30370073-B006062A-D5B1-41A4-A087-A0E71839E774 Q30370600-BF83E703-C320-4346-A2A2-C249345788A7 Q30855337-1B433701-0DB0-4456-BFBE-AE7D11B272F0 Q33614178-7A99AD42-8872-4B8C-A771-7D1833F78D8B Q33785739-007BC7B7-B157-4A98-80DD-6A4E1F7AF5A7 Q33842686-B9DC139B-B68B-443D-AA2E-549EF2963DB0 Q34547274-805C17E8-8C2B-4543-8159-48109BFC0823 Q34557243-3461A32F-A806-4870-AB08-D394B0C982D4 Q34557706-EC64DD2E-205B-4A3C-8B15-E6893B5E391A Q36770623-7FEEC663-6868-4A6C-BA84-7D86A6CC94A5 Q37399810-CCA5C90C-6A2A-43B3-A0EF-380961BF570E Q37490388-2DB93BE1-EAD5-4403-B2A7-8D27F22DCA91 Q37547285-D5E7C03F-BB95-48EC-A953-A6791DA0C433 Q37662689-6ABE58C7-99AA-4D1E-8E8B-4ACBBE01FF7F Q38673546-89ADEC6B-7689-440F-8E22-CD375D77487D Q38685420-4A452F25-5A5A-4D94-B565-443BC8957E2A Q38743867-EF531929-45B9-4ABC-8787-EE0986110FF6 Q38791739-5E0386FB-AA53-40D0-9C4E-731193971A2B Q38895017-5B21B574-2CD7-457D-ADEE-AF9ED63BDDF9 Q39008886-96E235A1-F7D1-4290-9BBB-B5F7627D948F Q39093325-D367F7DD-50A7-4CA0-A974-5BFA9B8B3BC7 Q39289997-12D7975C-F909-44B0-B239-3183D7561AC9 Q39307760-B99534C8-89F2-46CD-B95F-F358FD957E09 Q39494795-B31A62B6-6FE7-40F9-B9E4-CDC2860EB23C Q40097393-33DB5091-CC40-425A-82C5-CE2883E3ADB7 Q41903462-BE79E2D9-065B-48E4-928C-ADB8CF9F57DD Q42315149-42FE99A4-F6EA-4619-9068-E466074C6166 Q46075909-435FCD83-19C8-4C3C-884F-405CC2CB738F Q46237980-5120D448-E7D3-427C-8D61-57AF9B95DC15 Q46259903-FC9CE62F-802E-4C4A-A4D4-C757A040CD41 Q46383849-226B4F4F-CFA2-494F-9DB9-D14B53662265 Q47102871-AA596325-0D0C-4F51-94BA-13548C7D0FA5 Q47107894-10AE0F04-BD8A-45C8-ACB0-CD5844BC5AED Q47151084-C2EDC674-D48B-43BA-A1C5-A3392A5CA2FB Q47306135-A0E80B8B-1B55-45DE-85DD-CD7DAF420830 Q47403269-B8FA59BB-313A-4B91-999B-2CA0912DD1A3

P2860

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

http://www.wikidata.org/entity/Q28266846

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@ast

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@en

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@nl

type

label

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@ast

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@en

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@nl

prefLabel

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@ast

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@en

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@nl

P1433

Q28266846-6E940266-EBE5-4F3A-BA97-F9BC69B3CBBB

P1476

Q28266846-3E4C6505-A01E-48C2-BE01-B1B583BB30ED

P2093

Q28266846-154A3903-2EF2-4B26-ABBE-E64991CED5D3

Q28266846-2491CC6F-9DA2-45D2-B944-C691B1591B2A

Q28266846-962E3B22-91B2-4308-AB35-8B72E158AFE1

Q28266846-A8C0728C-9BF3-489C-94D8-34B9B6BE20B6

Q28266846-E6DE169C-D06F-4F3D-870E-6C587E160DC5

Q28266846-F62F4F1F-106D-45AD-9881-1AFC8C1DFA51

P2860

Q28266846-03842C36-EF93-476A-B954-787C252DE3DF

Q28266846-08B188C6-4471-42CB-B29E-B05E383BA96E

Q28266846-0A7CBAAA-0A5E-4021-8023-03AA995B71FA

Q28266846-0CE638A7-8582-487F-AECA-ABB0BBEC0C60

Q28266846-112D7664-1E56-4773-9880-2EC7114255A0

Q28266846-11AE0FAF-F5C7-4097-B1B0-EC384EB479E6

Q28266846-160944FB-C1E2-426F-ABC4-B796405C1044

Q28266846-17E6A545-A441-4F97-BC45-B94554F63F7E

Q28266846-215BEC86-019A-440A-9F41-C18FC89B0969

Q28266846-252C2867-CA70-47BB-9DB0-396844184243

P2888

Q28266846-FDCD5C39-48AA-41B2-80FF-D959DBC99A06

P304

Q28266846-A839C5E6-7B7A-40C1-A32A-F93DF0E240EA

P31

Q28266846-17395F72-BAFD-40FD-BFE8-A601500F05CE

P3181

Q28266846-3AB33847-177E-4C44-A1C4-7D6AE390E260

P356

Q28266846-4F994350-4EA7-403C-8065-1FB1813B7826

P407

Q28266846-8F81EEA7-5777-4E33-B070-CC11BBB6C2FA

P433

Q28266846-75C92716-AD8D-4882-9618-6A85DB5E693A

P478

Q28266846-E283A1C7-C093-4BCD-8E4E-98A32EBADEC4

P50

Q28266846-089C0D58-166E-4335-89EB-910F96F6452E

Q28266846-5873DE38-2288-4E5A-B654-CC434A4FC93C

P577

Q28266846-A132048F-863A-4162-841E-4B98F9D66552

P5875

Q28266846-1284804C-D585-4E85-A531-185A3C8539E7

P6179

Q28266846-17DEE052-A2C0-4D94-A412-E3596C8B40F2

P698

Q28266846-AD52C87C-FB30-4F18-9C8C-B9BCE9BD8CDC

P932

Q28266846-3B4D4A4D-14FB-43A9-A332-516855DB4CF1

P3181

P356

P1433

Translational Psychiatry

P1476

R-ketamine: a rapid-onset and ...... t psychotomimetic side effects

@en

P2093

C Dong

http://www.w3.org/2001/XMLSchema#string

C Yang

http://www.w3.org/2001/XMLSchema#string

J-c Zhang

http://www.w3.org/2001/XMLSchema#string

M Ma

http://www.w3.org/2001/XMLSchema#string

W Yao

http://www.w3.org/2001/XMLSchema#string

Y Shirayama

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

Antidepressant actions of ketamine: from molecular mechanisms to clinical practice

Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.

Inflammatory biomarkers as differential predictors of antidepressant response

Physiology and neurobiology of stress and adaptation: central role of the brain

R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

The mesolimbic dopamine reward circuit in depression

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

P2888

P304

e632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2639449

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/TP.2015.136

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281542184

http://www.w3.org/2001/XMLSchema#string

P6179

1030285572

http://www.w3.org/2001/XMLSchema#string

P698

26327690

http://www.w3.org/2001/XMLSchema#string

P932

5068814

http://www.w3.org/2001/XMLSchema#string